Imunon, Inc. (IMNN) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Imunon, Inc. (IMNN)
Company Research
Source: Seeking Alpha
Douglas V. Faller - Chief Medical Officer Jeffrey W. Church - Principal Financial Officer & Principal Accounting Officer Conference Call Participants Peter Vozzo Emily Bodnar - H.C. Wainwright & Co, LLC, Research Division James Molloy - Alliance Global Partners, Research Division Jason Mccarthy - Maxim Group LLC, Research Division Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Presentation Operator Good morning. My name is Desiree, and I will be your operator today. At this time, I would like to welcome you to Imunon's Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to Peter Vozzo of ICR Healthcare Investor Relations representative for Imunon. Please go ahead. Peter Vozzo Thank you, Desiree. Good morning, everyone, and welcome to Imunon's Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call. During today's call, manage
Show less
Read more
Impact Snapshot
Event Time:
IMNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNN alerts
High impacting Imunon, Inc. news events
Weekly update
A roundup of the hottest topics
IMNN
News
- Imunon (IMNN) was given a new $10.00 price target by Maxim Group.MarketBeat
- Imunon (IMNN) is now covered by Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.MarketBeat
- Imunon Inc (IMNN) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Management [Yahoo! Finance]Yahoo! Finance
- Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026 [Seeking Alpha]Seeking Alpha
- IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study [Yahoo! Finance]Yahoo! Finance
IMNN
Sec Filings
- 3/31/26 - Form 10-K
- 3/31/26 - Form 8-K
- 3/23/26 - Form 8-K
- IMNN's page on the SEC website